Sentence examples for focused maker from inspiring English sources

Two projects will create focused maker experiences to share with kids of the proper ages.

During the 1990s it set out to transform itself from a stodgy conglomerate to a more focused maker of specialty chemicals, starting with the sale of its pharmaceuticals arm, which is now part of AstraZeneca.

He did so because the deal allows him to make a leap in executing his most important strategic goal, to transform GE from a misfiring finance-heavy conglomerate into a more focused maker of industrial equipment.To meet this objective GE is also shrinking its finance business.

The fight to be the alpha male in the market for corporate data-storage networks, which are huge consumers of network bandwidth, is between two focused makers of storage switches, Brocade and McData.

Their idea is to focus maker movement efforts around textiles ("Makers' culture production of textile is kind of overlooked," they say).

The layoffs are apparently focused around Maker Media's digital assets, including MakerSpace, MakeZine, and MakerShed.

Back in April Nokia announced it was buying health and fitness focused gadget maker Withings for €170 million (~$190M).

The series of contagious currency crises in the 1990s in Mexico, Brazil, East Asia, and Argentina again focused policy makers' minds on the problems of the international monetary system.

To some extent this is a chicken and egg problem – until forecasts get better, they will not be valuable to worst case focused decision makers, but they won't get sufficiently customized until they are used on an operational basis.

These include personal contact between researchers and policy makers during the research; timeliness of the research; relevance of the research; research summarization focused on decision maker needs; and inclusion of budgetary considerations within the research [ 25, 26].

Yet European investigators also appear to be focusing on makers of generics, asking whether they have accepted payments from brand-name drug makers as part of patent litigation, perhaps in exchange for introducing a medicine later than intended.